Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription

Nature Immunology

Volumn 5, Issue 10, 2004, Pages 1069-1077

  Maier, Holly ^a,b   Ostraat, Rachel ^a,b   Gao, Hua ^b   Fields, Scott ^a,b   Shinton, Susan A ^c   Medina, Kay L ^d   Ikawa, Tomokatsu ^e   Murre, Cornelis ^e   Singh, Harinder ^d   Hardy, Richard R ^c   Hagman, James ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD79A ANTIGEN; DINUCLEOTIDE; HELIX LOOP HELIX PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR RUNX1; CD79 ANTIGEN; CD79A PROTEIN, MOUSE; DNA BINDING PROTEIN; EBF1 PROTEIN, MOUSE; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; ONCOPROTEIN; PAX5 PROTEIN, MOUSE; RUNX1 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ARTICLE; B LYMPHOCYTE; CELL LINE; CELL MATURATION; EPIGENETICS; GENETIC CODE; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; LYMPHOPOIESIS; METHYLATION; NUCLEOSOME; PLASMACYTOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CHEMISTRY; CHROMATIN; DEALKYLATION; GENETICS; MOUSE; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD79; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; CHROMATIN; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DEALKYLATION; DNA-BINDING PROTEINS; MICE; MICE, INBRED C57BL; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; RECEPTORS, ANTIGEN, B-CELL; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 5444222634     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1119     Document Type: Article

References (46)

1. Wang, Q. et al. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA 93, 3444-3449 (1996).
2. Okuda, T., van Deursen, J., Hiebert, S., Grosveld, G. & Downing, J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321-330 (1996).
3. Wang, Q. et al. The CBFβ subunit is essential for CBFα2 (AML1) function in vivo. Cell 87, 697-708 (1996).
4. Zhang, D.E. et al. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBFα2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol. Cell Biol. 16, 1231-1240 (1996).
5. Taniuchi, I. et al. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111, 621-633 (2002).
6. Libermann, T.A. et al AML1 (CBFα2) cooperates with B cell-specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter. J. Biol. Chem. 274, 24671-24676 (1999).
7. Ichikawa, M. et al. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 10, 299-304 (2004).
8. Borghesi, L. et al. B lineage-specific regulation of V(D)J recombinase activity is established in common lymphoid progenitors. J. Exp. Med. 199, 491-502 (2004).
9. Bain, G. et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79, 885-892 (1994).
10. Lin, H. & Grosschedl, R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376, 263-267 (1995).
11. Urbanek, P., Wang, Z.Q., Fetka, I., Wagner, E.F. & Busslinger, M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79, 901-912 (1994).
12. Hagman, J., Belanger, C., Travis, A., Turck, C.W. & Grosschedl, R. Cloning and functional characterization of early B-cell factor, a regulator of lymphocyte-specific gene expression. Genes Dev. 7, 760-773 (1993).
13. Hagman, J., Travis, A. & Grosschedl, R. A novel lineage-specific nuclear factor regulates mb-1 gene transcription at the early stages of B cell differentiation. EMBO J. 10, 3409-3417 (1991).
14. O'Riordan, M. & Grosschedl, R. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 11, 21-31 (1999).
15. Sigvardsson, M. Overlapping expression of early B-cell factor and basic helix-loop-helix proteins as a mechanism to dictate B-lineage-specific activity of the lambda5 promoter. Mol. Cell Biol. 20, 3640-3654 (2000).
16. Goebel, P. et al. Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells. J. Exp. Med. 194, 645-656 (2001).
17. Sigvardsson, M. et al. Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B cell-specific mb-1 promoter. Mol. Cell Biol. 22, 8539-8551 (2002).
18. Gisler, R. & Sigvardsson, M. The human VpreB promoter is a target for coordinated activation by early B cell factor and E47. J. Immunol. 168, 5130-5138 (2002).
19. Sigvardsson, M., O'Riordan, M. & Grosschedl, R. EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. Immunity 7, 25-36 (1997).
20. Fitzsimmons, D. et al. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev. 10, 2198-2211 (1996).
21. Maier, H., Colbert, J., Fitzsimmons, D., Clark, D.R. & Hagman, J. Activation of the early B-cell-specific mb-1 (Ig-α) gene by Pax-5 is dependent on an unmethylated Ets binding site. Mol. Cell Biol. 23, 1946-1960 (2003).
22. Hardy, R.R., Carmack, C.E., Shinton, S.A., Kemp, J.D. & Hayakawa, K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173, 1213-1225 (1991).
23. Gonzalgo, M.L. & Jones, P.A. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (MS-SNuPE). Nucleic Acids Res. 25, 2529-2531 (1997).
24. Wotton, D., Ghysdael, J., Wang, S., Speck, N.A. & Owen, M.J. Cooperative binding of Ets-1 and core binding factor to DNA. Mol. Cell Biol. 14, 840-850 (1994).
25. Schebesta, M., Heavey, B. & Busslinger, M. Transcriptional control of B-cell development. Curr. Opin. Immunol. 14, 216-223 (2002).
26. Maier, H. et al. Requirements for selective recruitment of Ets proteins and activation of mb-1/Ig-α gene transcription by Pax-5 (BSAP). Nucleic Acids Res. 31, 5483-5489 (2003).
27. Hombach, J., Leclercq, L., Radbruch, A., Rajewsky, K. & Reth, M. A novel 34-kd protein co-isolated with the IgM molecule in surface IgM-expressing cells. EMBO J. 7, 3451-3456 (1988).
28. Hombach, J., Sablitzky, F., Rajewsky, K. & Reth, M. Transfected plasmacytoma cells do not transport the membrane form of IgM to the cell surface. J. Exp. Med. 167, 652-657 (1988).
29. Ikawa, T., Kawamoto, H., Wright, L.Y.T. & Murre, C. Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent. Immunity 20, 349-360 (2004).
30. Seet, C.S., Brumbaugh, R.L. & Kee, B.L. Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A. J. Exp. Med. 199, 1689-1700 (2004).
31. Travis, A., Hagman, J. & Grosschedl, R. Heterogeneously initiated transcription from the pre-B- and B-cell-specific mb-1 promoter: analysis of the requirement for upstream factor-binding sites and initiation site sequences. Mol. Cell Biol. 11, 5756-5766 (1991).
32. Otto, F. et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-771 (1997).
33. Inoue, K. et al. Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat. Neurosci. 5, 946-954 (2002).
34. Levanon, D. et al. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J. 21, 3454-3463 (2002).
35. Li, Q.L. et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109, 113-124 (2002).
36. Meyers, S., Lenny, N., Sun, W. & Hiebert, S.W. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Oncogene 13, 303-312 (1996).
37. Romanow, W.J. et al. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol. Cell 5, 343-353 (2000).
38. Lundgren, M. et al. Transcription factor dosage affects changes in higher order chromatin structure associated with activation of a heterochromatic gene. Cell 103, 733-743 (2000).
39. Medina, K.L. et al. Assembling a gene regulatory network for specification of the B cell fate. Dev. Cell (in the press).
40. Julius, M.H., Janusz, M. & Lisowski, J. A colostral protein that induces the growth and differentiation of resting B lymphocytes. J. Immunol. 140, 1366-1371 (1988).
41. Swift, S., Lorens, J., Achacoso, P. & Nolan, G.P. in Current Protocols in Immunology (Online) (eds. Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M. & Strober, W.) Unit 10.17C (John Wiley & Sons, New York, 2003).
42. Quong, M.W., Harris, D.P., Swain, S.L. & Murre, C. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J. 18, 6307-6318 (1999).
43. Hawley, R.G., Lieu, F.H., Fong, A.Z. & Hawley, T.S. Versatile retroviral vectors for potential use in gene therapy. Gene Therapy 1, 136-138 (1994).
44. Naviaux, R.K., Constanzi, E., Haas, M. & Verma, I.M. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70, 5701-5705 (1996).
45. Wagner, D.H., Jr. et al. Thymocytes are rescued from glucocorticoid- mediated cell death by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2. J. Exp. Med. 184, 1631-1638 (1996).
46. Schreiber, E., Matthias, P., Muller, M.M. & Schaffner, W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17, 6419 (1989).